论文部分内容阅读
乙胺碘呋酮(Amiodarone,Cordarone)是若干新的抗心律失常药物之一,是一种平滑肌及血管肌的舒张剂,早期临床应用于治疗冠心病心绞痛,效果尚良好。其主要临床用途是治疗室上性和室性心律失常。1974年Rosenbaum等报告本药能完全抑制预激综合征伴有的过速性心律失常,效果显著。该作者也证明乙胺碘呋酮对不同类型心脏病患者的多种类型过速性心律失常具有抑制能力,虽然本药的主要治疗经验来自成人,但在儿童中88%的患儿也有良好或中等良好效果。在欧洲与南美洲已应用于临床。此药在我国已逐步广泛的应用于心血管内科。
Amiodarone (Cordarone) is one of several new anti-arrhythmic drugs. It is a kind of smooth muscle and vasodilator. It has been used clinically in the treatment of angina pectoris of coronary heart disease in the early stage, and the effect is good. Its main clinical use is the treatment of supraventricular and ventricular arrhythmias. In 1974 Rosenbaum other reports of the drug can completely inhibit the WPW syndrome accompanied by tachyarrhythmia, the effect is significant. The authors also demonstrated that amiodarone inhibits various types of tachyarrhythmia in patients with different types of heart disease. Although the mainstay of treatment for this drug is from adults, 88% of children have good or Medium good result. Has been used clinically in Europe and South America. This medicine has been widely used in cardiovascular medicine in our country.